Software use for assessing complication rates by Maryland Hospitals

July is being sought as the month for starting new reimbursement program by the state, by Maryland hospitals.

Ranbaxy starts phase III study of anti-malaria drug

Ranbaxy Laboratories announced that its new anti-malarial combination drug is now undergoing final stage of development. In its press-release, the company said that the drug is targeted at patients in developing countries with the aim of significantly improving upon the conventional options available for the treatment of P falciparum malaria.

Engineering Bio-Medical Marvels : Dr. Rajat Aggarwal, Implants, University of Southern California

In addition to the routine clinical work, Dr. Agarwal is involved in the Artificial Retinal Implant project, being carried out in collaboration with Texas Instruments, which aims at developing a complex artificial epiretinal device in patients with advanced retinitis pigmentosa and age-related macular degeneration, which will help these patients see again.

Satellite monitoring can predict cholera outbreaks in India

Scientists have found that cholera outbreaks can be predicted using satellite monitoring of marine environments, especially in India and Bangladesh where such epidemics occur regularly.

Ayurveda doctors sharpen skills with latest technology

The Government of India

Apollo DKV health insurance in ties with InsuranceMall

Apollo DKV Insurance recently announced its tie-up with Bonsai Insurance Broking Pvt. Ltd., a leading Insurance Broker in the General Insurance segment for online insurance shopping through its website www.Insurancemall.in.

NEWS REVIEW – INDIA

[This article was published in the February 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

NEWS REVIEW

Singapore’s Parkway eyes 50% stake in Khubchandani (Mumbai)

Singapore’s Parkway Group, which owns one of Asia’s largest hospital chains, plans to pick up 50% stake in Mumbai-based Khubchandani Hospitals for INR 155 crore.

ICICI Venture plans to float healthcare holding firm

ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund

ICICI Venture plans to float healthcare holding firm

ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund

ICICI Venture plans to float healthcare holding firm

ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund

ICICI Venture plans to float healthcare holding firm

ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund

Fortis ventures into South India

The Fortis group recently announced their decision to buy 48% stake in Chennai-based Malar Hospital for around Rs 42 crore. This move will mark the group’s first entry in South India.